This document summarizes Bayer's sustainability strategies and actions from 2019 to 2030 across several key challenges: 1) Unethical testing - Reducing animal testing by 50% by 2025 and stopping outsourcing of tests. 2) Aging society - Focusing on early disease detection and increasing biopharmaceutical medicines to 60% of products by 2030. 3) Packaging - Reducing excessive packaging through individual prescriptions and sustainable suppliers. 4) Loss of biodiversity - Reducing environmental impact 30% by 2030 through sustainable agriculture and bee protection programs. 5) Unethical production - Ensuring suppliers balance resource use to restore biodiversity in line with UN and EU sustainability

1. Managing Sustainable Enterprises:
Assignment 2/ Group 5
Case Study „Bayer“
Kseniia
Fawad
Friederike Krischer
Aikinola
30.11.2019

2. Towards a bright future – The journey since 2019

4. Key Challenges in 2019
1

5. WE STRIVE TO …
Key Actions
use innovative ideas and methods to be able…
Using market power to force partners into our vision.
to take responsible action ensuring…

6. UNETHICAL TESTING
Key Actions
3Rs” –Reducing the number of animals used in studies, refining study
methods, Replacing animal studies with new methods.
Small animal imaging allows us less invasive testing while nonetheless
providing meaningful scientific results.
Partnerships with other companies and universities for developing
alternative methods and reducing the use of animals in legally required
studies.
2019 20302025
Less than 50% of
animal testingStoping outsourcing139000 animals in testing

7. AGING SOCIETY
Key Actions
Focus on provision of new methods of early detection for
diseases
Pioneering in data collection, analysis and interpretation:
 Eisei Case Study
Intensified research in Biomedicine:
 Until 2030 60% of our medicine should be
biopharmaceuticals
Using market power to force partners into our vision:
Supply Chain Management
2019 2030
Release of strategy
Cooperation with Eisei
Launch of the
„Bayer Health Care App“
2021
Interim Status Check Up
Of Biomedicine Goal
2025

8. PACKAGING
Key Actions
Rethinking the usage of abundant packaging in medicine
Use patient profiles to individualise personal prescriptions
(reduce packaging)
Partner up with sustainable suppliers
Create a hub with other pharmaceutical companies to gather
ideas regarding sustainable packaging
2019 20302025
Start of data
gathering
Evaluate Companies
Package Usage
First Int. Forum for
Sustainable Medical
Packaging

9. LOSS OF BIODIVERSITY
Key Actions
Ensure that the suppliers of herbal pharmaceuticals find the right balance in
the use of natural resources so that enough remains to enable regeneration.
Developing of new technologies, scaling down crop protection volumes, and
enabling more precise application to restore and retain biodiversity, combat
climate change, and make the most efficient use of natural resources
2019 2030
BeeCare Program
2020
Reduce the environmental
impact by 30% by 2030
20252021
Forward Farming
In partnership with independent farmers show how modern agriculture can
go hand in hand with environmental and social responsibility

10. AGING SOCIETY
LOSS OF BIODIVERSITY
UNETHICAL PRODUCTION
UN 17 Sustainable Development Goals.
15.5. Take urgent and significant action to reduce the degradation of
natural habitats, halt the loss of biodiversity and, by 2020, protect and
prevent the extinction of threatened species.
WHO Action Plan on Ageing and Health.
4.1. Establish and continually improve a sustainable and equitable long-
term care system
The European Union (EU) Directive 2010/63
Framework

11. Laws and regulations
Different patent laws and regulations across
countries make it difficult to work efficient
Economical Conflicts
Developing medicine is costly and time
consuming
Areas of Conflict

12. Sustainable
Science for a
Better Life
Biopharma
Crop Shience
and Animal
Health
Consumer
Health
sustainability integritytransparency
Mission, Vision and Core Values until 2040
What do we see in the future?

13. References
Bayer Global: Profil und Organisation, Company Website, https://www.bayer.de/de/strategie.aspx, Accessed: 29.11.2019
Bee Carefull: Fruit Diversity, http://www.bee-careful.com/fruit-diversity/value-bees-mankind/ Accessed: 29.11.2019
Chivian, E. and A. Bernstein. (2008). Sustaining life: How human health depends on biodiversity. Center for Health and the Global
Environment. Oxford University Press, New York.
Neergheen-Bhujun, V., Awan, A. T., Baran, Y., Bunnefeld, N., Chan, K., Cruz, T. E. D., … Kagansky, A. (2017). Biodiversity, drug
discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action. Journal of
Global Health, 7(2).
Resolution Adopted by the General Assembly on 25 September 2015. (2019). Sustainable Development Goals, 333–374.
World Health Organisation: SDG 3 Ensure healthy lives and promote well being for all at all ages, Accessed: 30.11.2019